DUBLIN--(BUSINESS WIRE)--The "High Content Screening/Imaging: Technologies and Global Markets 2021-2026" report has been added to ResearchAndMarkets.com's offering.
The global market for high content screening/imaging technology should grow from $1.2 billion in 2021 to $2.3 billion by 2026 with a compound annual growth rate (CAGR) of 13.5% for the period of 2021-2026.
The North American market for high content screening/imaging technology should grow from $448.2 million in 2021 to $744.1 million by 2026 with a compound annual growth rate (CAGR) of 10.7% for the period of 2021-2026.The European market for high content screening/imaging technology should grow from $336.8 million in 2021 to $674.5 million by 2026 with a compound annual growth rate (CAGR) of 14.9% for the period of 2021-2026
The current report offers a detailed picture of the high content screening/imaging market. This report highlights the current and future market potential for high content screening/imaging and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities and trends in the market. The report also covers market projections through 2026, as well as key market players.
This report discusses the high content screening/imaging industry and its various resources. It covers the overall high content screening/imaging market including instrument or platform, consumables (reagents and kits), software and analytics, and services. The report further analyzes the market based on application, providing an analysis of drug discovery, oncology, compound profiling, molecular diagnosis, toxicity studies and neuroscience. A complete regional analysis of the market is also studied in the report.
Companies Mentioned
- Albany Molecular Research Inc. (Amri)
- Aurelia Bioscience Ltd.
- Axxam Spa
- Becton, Dickinson And Co.
- BioTek (Agilent)
- Charles River
- Corning Inc.
- Creative Biolabs
- Curiox Biosystems Inc.
- Cytoo Sa
- Danaher Corp.
- De Novo Software
- Discoverx Corp.
- Essen Bioscience (Sartorius)
- Fluxion Biosciences
- Genedata Ag
- Hudson Robotics Inc.
- Instrument Systems
- Logos Biosystems
- Lumencor Inc.
- Merck Millipore
- Molecular Devices (Danaher)
- Olympus Corp.
- Perkinelmer Inc.
- Phenovista Biosciences Llc
- Platypus Technologies
- Tecan Group Ltd.
- Thermo Fisher Scientific Inc.
- Thorlabs Inc.
- Vala Sciences Inc.
- Yokogawa Electric Corp.
The Report Includes
- 44 data tables and 28 additional tables
- An overview of the global markets and technologies for high content screening/imaging
- Estimation of the market size and analyses of market trends, with data from 2019, 2020, estimates for 2021 and projection of CAGR through 2026
- Quantification of high content screening/imaging market based on component, end user, application, and region, and analysis of market drivers, restraints and other forces impacting the global market
- Highlights of the current and future market potential, detailed analysis of the regulatory framework and policies and information on new technologies and innovations of the industry
- Discussion on advantages of high-throughput screening over manual screening, and COVID-19 impact on MedTech and medical tourism
- Coverage of recent developments, research and development (R&D) exploration, clinical trials and government programs to predict market trends of the HCS/I market
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies and a relevant patent analysis
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
- Overview
- Scanning Probe Microscopy
- Scanning Electron Microscopy
- Transmission Electron Microscopy
- Technological Advancements
- Cytometers
- Detectors/Sensors
- Liquid Handling Instruments
- Process Overview
- High Content Screening (HCS)
- High Throughput Screening (HTS)
Chapter 4 Impact of COVID-19 Pandemic
- Introduction
- Impact on MedTech
- Elective and Noncritical Procedures
- Shift in Manufacturing
- Regulatory Delays, Clinical Trials and Product Launches
- Supply Chain Disruptions
- Medical Tourism
Chapter 5 Market Dynamics
- Market Drivers
- Increasing R&D Budget
- Advantages Over Manual and High-Throughput Screening
- Technological Advancements in High Content Screening/Imaging
- Market Restraints
- Expensive Equipment
- Inadequate Infrastructure and Funding for R&D in Emerging Countries
- Market Opportunities
- Opportunities in Various 3D Applications
- Emerging Economies
Chapter 6 Market Breakdown by Component
Chapter 7 Market Breakdown by Application
Chapter 8 Market Breakdown by End User
Chapter 9 Market Breakdown by Region
Chapter 10 Patent Review
- Introduction
- Patents Issued by Publication Year, 2015-2017
Chapter 11 Competitive Landscape
- Overview
- Company Share Analysis
- Strategies
- Regional Distributors
- End Users
- Recent Developments
Chapter 12 Pricing Analysis of Instruments by Major Players
- Thermo Fisher Scientific
- Molecular Devices (Danaher)
- Yokogawa Electric Corp.
- BioTek (Agilent)
- Essen Bioscience (Sartorius)
- Logos Biosystems
- Other Major Players
Chapter 13 Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/wbfg96
